Skip to content

CTEV CTEV Treasury Stock

Treasury Stock at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$61.43M+191%
Corvel logo
CorvelCRVL
$887.72M+6.8%
ROP
Roper Technologies, Inc.ROP
$2.02B+12,317%
Phreesia logo
PhreesiaPHR
$46.62M+2.4%
IQVIA logo
IQVIAIQV
$11.91B+13.1%
ExlService Holdings logo
ExlService HoldingsEXLS
$1.26B+56.6%

Other financials

Income statement

See full
Revenue$244.7M+5.8%
Gross profit$175.6M+2.8%
Operating income$6.6M-31.9%
Net income-$73.6M-3.1%
EPS (diluted)-$4.41-0.7%

Balance sheet

See full
Cash & equivalents$34.7M+2.4%
Total debt$4.7B+1.1%
Total equity-$241.1M-1,727%
Total assets$4.8B-4.8%

Cash flow

See full
Operating cash flow-$45.8M-52.3%
CapEx$46.8M+20.3%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$591.9M-10.0%
Enterprise value$5.22B
P/S0.6×

Profitability

See full
Gross margin73.2%-0.9pp
Operating margin-0.5%-0.3pp
Net margin-29.3%-12.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by CTEV in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: CTEV’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CTEV's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CTEV's treasury stock?
CTEV (CTEV) reported treasury stock of $138.73M in Q1 2026.
How has CTEV's treasury stock changed year-over-year?
CTEV's treasury stock decreased by 0.0% year-over-year, from $138.73M to $138.73M.
What is the long-term trend for CTEV's treasury stock?
Over 5 years (2020 to 2025), CTEV's treasury stock has grown at a 9.2% compound annual growth rate (CAGR), from $89.5M to $138.73M.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.